DrugBiological
AADvac1 clinical trials
- studies test it
- 8
- open now
- 4
- in phase 3
- 0
- first study started
- 2013
Keep track of what changes. Save the AADvac1 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
8 studies that test it; most in 2026 (4)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 4
Axon Neuroscience SE (4) · Paul S. Aisen (2) · Adam Boxer (2)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses AADvac1 is read from its arms, and is right about nine times in ten.
Testing it · 8
- The Progressive Supranuclear Palsy Clinical Trial PlatformRecruitingPhase 2Adam BoxerNCT07173803Written as AADvac1
- Alzheimer's Tau Platform: Regimen A - AADvac1Enrolling by invitationPhase 2Paul S. AisenNCT07167966Written as AADvac1
- Alzheimer's Tau Platform: Master ProtocolRecruitingPhase 2Paul S. AisenNCT06957418Written as AADvac1
- The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1Enrolling by invitationPhase 2Adam BoxerNCT07217665Written as AADvac1
- 24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's DiseaseCompletedPhase 2Axon Neuroscience SENCT02579252Written as AADvac1
- A 24-month Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive AphasiaStatus unknownPhase 1Axon Neuroscience SENCT03174886Written as AADvac1 40 µg
- 18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's DiseaseCompletedPhase 1Axon Neuroscience SENCT02031198Written as AADvac1
- Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's DiseaseCompletedPhase 1Axon Neuroscience SENCT01850238Written as AADvac1
Codes
What other systems call AADvac1 · ClinicalTrials.gg INT001393
- MeSH (NLM) C000709631AADvac1One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000709631 | AADvac1 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.